marijuana stocks news

Tauriga Sciences Inc. Creates Alternative Version of its Graphic Design for Mint Flavor Tauri-Gum Blister Pack

Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue-generating Company that operates through the development, distribution, and licensing of proprietary products as well as the evaluation of potential acquisition opportunities and equity investments, today announced that it has created an alternative version of its graphic design & artwork (“design”) for its Tauri-GumTMblister pack.  Additionally, there was a slight design modification incorporated into the retail display box to correlate with the above-mentioned alternative version.  This alternative version is largely defined by the removal of the Cannabis Leaf from the existing blister pack design.  Concerning its Mint flavor Tauri-GumTM blister pack, the Company’s digital artist has replaced the Cannabis Leaf with a green Mint Leaf.

The Company believes that its recent decision to create an alternative version of its blister pack design is an important step towards the meaningful expansion of its potential customer base.  The Company has recently held discussions with several   national retail chains of substantial size (in terms of revenue and footprint).  The Company believes that there is genuine interest in its Tauri-GumTM product line, however the feedback regarding the packaging (graphic design) necessitated the creation of a more conservative alternative version.  The Company continues to have great confidence in its original blister pack design (inclusive of Cannabis Leaf) and is pleased with the progress being realized on a number of important initiatives.

ABOUT TAURIGA SCIENCES INC.

Tauriga Sciences, Inc. (TAUG) is a revenue generating Company that operates through the development, distribution, and licensing of proprietary products as well as the evaluation of potential acquisition opportunities. One such opportunity on which the Company has acted, involves the Company having entered into the cannabidiol (or “CBD”) infused chewing gum product business, as more fully described above and in prior press releases.  This CBD infused chewing gum product has been branded under the following name: Tauri-GumTM.  See also our periodic reports filed by us with the SEC for a more complete description of our business and material agreements that we have entered into.  Further, the Company continues to identify and evaluate additional potential opportunities to generate revenue, as well as shareholder value, and leverage its resources and expertise to build a diversified and sustainable business model. Please visit our corporate website at www.tauriga.com.

In addition, on March 11, 2019, the Company announced the official launch of its E-Commerce site – as part of its Tauri-GumTM commercialization strategy.  This site can be accessed by visiting the following URL address:  www.taurigum.com

Forward-Looking Statements

This press release contains certain “forward-looking statements” as defined by the Private Securities Litigation Reform Act of 1995 which represent management’s beliefs and assumptions concerning future events. These forward-looking statements are often indicated by using words such as “may,” “will,” “expects,” “anticipates,” believes, “hopes,” “believes,” or plans, and may include statements regarding corporate objectives as well as the attainment of certain corporate goals and milestones. Forward-looking statements are based on present circumstances and on management’s present beliefs with respect to events that have not occurred, that may not occur, or that may occur with different consequences or timing than those now assumed or anticipated. Actual results may differ materially from those expressed in forward looking statements due to known and unknown risks and uncertainties, such as are not guarantees of general economic and business conditions, the ability to successfully develop and market products, consumer and business consumption habits, the ability to consummate successful acquisition and licensing transactions, fluctuations in exchange rates, and other factors over which Tauriga has little or no control. Many of these risks and uncertainties are discussed in greater detail in the “Risk Factors” section of Tauriga’s Form 10-K and other filings made from time to time with the Securities and Exchange Commission. Such forward-looking statements are made only as of the date of this release, and Tauriga assumes no obligation to update forward-looking statements to reflect subsequent events or circumstances. You should not place undue reliance on these forward-looking statements.

Contact:

CONTACT INFORMATION

Tauriga Sciences, Inc.
555 Madison Avenue, 5th Floor
New York, NY  10022
Chief Executive Officer
Mr. Seth M. Shaw
Email:  sshaw@tauriga.com
cell # (917) 796 9926
Corporate Website:   www.tauriga.com
E-Commerce Site:    www.taurigum.com

  • Tauriga Sciences, Inc.

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

AbbVie Inc. (ABBV) RINVOQ® (upadacitinib) Receives Health Canada Approval

AbbVie’s RINVOQ® (upadacitinib) Receives Health Canada Approval as the First and Only…

Cara Therapeutics, Inc. (CARA) to Present at the Canaccord Genuity 43rd Annual Growth Conference

Cara Therapeutics to Present at the Canaccord Genuity 43rd Annual Growth Conference…

Global Consortium, Inc., (GCGX) to supply $50,000 of product weekly to MJ Delivery company

Global Consortium, Inc., to supply $50,000 of product weekly to MJ Delivery…

Lifestyle Delivery Systems Inc. (LDSYF) Affiliate Submits Plans for the Construction of Dispensary in Adelanto, California

Lifestyle Delivery Systems Inc.’s Affiliate Submits Plans for the Construction of Dispensary…